1. Inflammation and cancer: Till death tears them apart
    T.P. Raposo et al, 2015, The Veterinary Journal CrossRef
  2. High COX‐2 expression is associated with increased angiogenesis, proliferation and tumoural inflammatory infiltrate in canine malignant mammary tumours: a multivariate survival study
    M. I. Carvalho et al, 2017, Veterinary and Comparative Oncology CrossRef
  3. Evaluation of Cytotoxic Potentials of Novel Cyclooxygenase-2 Inhibitor against ALL Lymphocytes and Normal Lymphocytes and Its Anticancer Effect through Mitochondrial Pathway
    Ahmad Salimi et al, 2020, Cancer Investigation CrossRef
  4. Chronic pain management in the home setting
    Lynn Hendrix et al, 2023, Animal Hospice and Palliative Medicine for the House Call Veterinarian CrossRef
  5. Current biomarkers of canine mammary tumors
    Ilona Kaszak et al, 2018, Acta Veterinaria Scandinavica CrossRef
  6. COX-2 expression in mammary invasive micropapillary carcinoma is associated with prognostic factors and acts as a potential therapeutic target in comparative oncology
    Thaynan Cunha Vieira et al, 2022, Frontiers in Veterinary Science CrossRef
  7. Metabolites derived from omega-3 polyunsaturated fatty acids are important for cardioprotection
    Kim Gilbert et al, 2015, European Journal of Pharmacology CrossRef
  8. Canine Mammary Cancer: State of the Art and Future Perspectives
    Eliza Vazquez et al, 2023, Animals CrossRef
  9. Adjuvant therapy for highly malignant canine mammary tumours: Cox‐2 inhibitor versus chemotherapy: a case–control prospective study
    C. Arenas et al, 2016, Veterinary Record CrossRef
  10. The use of cyclooxygenase-2 inhibitors for improvement of efficacy of radiotherapy in cancers
    Ebrahim Salehifar et al, 2016, Drug Discovery Today CrossRef
  11. Firocoxib as a Potential Neoadjuvant Treatment in Canine Patients with Triple-Negative Mammary Gland Tumors
    Andressa Brandi et al, 2022, Animals CrossRef
  12. Celecoxib exerts antitumor effects in canine mammary tumor cells via COX-2-independent mechanisms
    DAI TAMURA et al, 2015, International Journal of Oncology CrossRef
  13. Mechanisms of modulation of the Egr gene family in mammary epithelial cells of different species
    P. Santino et al, 2017, General and Comparative Endocrinology CrossRef
  14. From Conventional to Precision Therapy in Canine Mammary Cancer: A Comprehensive Review
    Guillermo Valdivia et al, 2021, Frontiers in Veterinary Science CrossRef
  15. Meloxicam decreases the migration and invasion of CF41.Mg canine mammary carcinoma cells
    María P. Iturriaga et al, 2017, Oncology Letters CrossRef
  16. A New Ibuprofen Derivative Inhibits Platelet Aggregation and ROS Mediated Platelet Apoptosis
    Kodagahalli S. Rakesh et al, 2014, PLoS ONE CrossRef
  17. Investigating associations of cyclooxygenase-2 expression with angiogenesis, proliferation, macrophage and T-lymphocyte infiltration in canine melanocytic tumours
    Hugo Gregório et al, 2016, Melanoma Research CrossRef